Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody
to evaluate the prognosis of non-small cell lung carcinoma patients under CIK cellular treatment with PD-1 blocking on top of the standard therapy
Non-small Cell Lung Cancer
BIOLOGICAL: CIK cells with PD-1 blocking|OTHER: standard lung cancer treament|BIOLOGICAL: CIK cells without PD-1 blocking
progression-free survival, 5 years|metastasis-free survival, 5 years
to evaluate the prognosis of non-small cell lung carcinoma patients under CIK cellular treatment with PD-1 blocking on top of the standard therapy